Study guide
2.11 Radiation Safety Rules, Emergency Procedures & Sealed Source Safety
ARRT Radiation Therapy Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient Care & Education
1.1 Patient Assessment, History, and Vital Signs 1.2 Psychosocial Support & Coping Mechanisms 1.3 Patient & Family Education on Radiation Therapy 1.4 Radiation Side Effect Management: Skin & Mucosal Reactions 1.5 Radiation Side Effect Management: Systemic & Organ-Specific Side Effects 1.6 Nutritional Support & Management of Dysphagia/Odynophagia 1.7 Medical Emergencies in Radiation Oncology 1.8 Patient Rights, Informed Consent, and Advanced Directives 1.9 Ethical, Legal, and HIPAA Considerations for Radiation Therapists 1.10 Infection Control & Sterile Technique in Radiation Therapy 1.11 Transfer & Positioning Safety for Oncology Patients 1.12 Pharmacology & Contrast Media in Radiation Therapy 1.13 Cancer Epidemiology, Screening & Diagnostic Evaluation
2 Chapter 2: Radiation Physics, Radiobiology & Protection
2.1 Structure of Matter, Electromagnetic & Particulate Radiation 2.2 Radiation Production in Linear Accelerators & X-Ray Tubes 2.3 Photon & Electron Beam Interactions with Matter 2.4 Radiation Measurement Quantities, Units & Dosimeters 2.5 Radiation Protection Principles: ALARA, Time, Distance & Shielding 2.6 NCRP Dose Limits for Occupational & Public Exposure 2.7 Vault Design, Primary & Secondary Protective Barriers 2.8 Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's) 2.9 Linear Energy Transfer (LET) & Relative Biological Effectiveness (RBE) 2.10 Acute & Late Radiation Effects on Normal Tissues 2.11 Radiation Safety Rules, Emergency Procedures & Sealed Source Safety 2.12 MRI Magnetic Field Screening for Radiation Therapy Patients
3 Chapter 5: Treatment Sites, Tumors & Classification
5.1 Brain, Spinal Cord Tumors & Metastatic Patterns 5.2 Head & Neck Sites: Anatomy, Lymphatics & Patterns of Spread 5.3 Breast Cancer: Anatomy, Lymphatic Drainage & Radiation Considerations 5.4 Lung & Thoracic Tumors: Anatomy, Spread & Critical Structures 5.5 Abdomen, Pelvis, GI & GU Sites: Anatomy & Metastatic Patterns 5.6 Reproductive System Tumors: Prostate, Cervix & Related Sites 5.7 Lymphoma, Sarcoma, Skin, Leukemia & Oncologic Emergencies 5.8 Tumor Classification: Histopathology, Grade & Staging Systems
4 Chapter 3: Treatment Planning & Dosimetry
3.1 CT Simulation, Patient Positioning & Target Localization 3.2 Immobilization Devices & Radiopaque Marking Protocols 3.3 ICRU Target Volume Definitions (GTV, CTV, PTV, PRV, OAR) 3.4 Beam Modifiers: Wedges, Compensators, Bolus & MLC Systems 3.5 Depth Dose Characteristics: PDD, TMR, TPR & TAR Relationships 3.6 Monitor Unit (MU) Calculations & Clinical Dosimetry Formulas 3.7 3D Conformal Radiation Therapy (3D-CRT) Beam Arrangements 3.8 IMRT, VMAT & Inverse Planning Optimization Concepts 3.9 SRS, SBRT & Stereotactic Radiosurgery Techniques 3.10 Brachytherapy Principles, HDR, LDR & Isotopes 3.11 Dose Volume Histograms (DVH) & QUANTEC Tissue Tolerances
5 Chapter 4: Treatment Delivery, Image Guidance & QA
4.1 Pre-Treatment Chart Check & Plan Verification Protocols 4.2 Daily Patient Positioning, Setup Tolerances & Alignment Verification 4.3 Image-Guided Radiation Therapy (IGRT): Portal Imaging & CBCT Verification 4.4 Linear Accelerator Safety Systems, Interlocks & Gantry Controls 4.5 Special Techniques: TBI, TSI, SGRT & Gated Radiotherapy 4.6 Daily Linac Quality Assurance per AAPM TG-142 Specifications 4.7 Monthly & Annual Linac QA Requirements & Dosimetric Calibration 4.8 Patient-Specific IMRT QA & In-Vivo Dosimetry Verification 4.9 Machine Malfunctions, Override Protocols & Emergency Off Procedures 4.10 Record and Verify (R&V) Systems, EHR Integration & Treatment Documentation
2.11 Radiation Safety Rules, Emergency Procedures & Sealed Source Safety
Key Takeaways Explain This Topic AI
HDR remote afterloading keeps the high-activity source stored shielded until treatment; protection planning assumes a stuck-source emergency can occur.
ARRT emphasizes basic brachytherapy uses, surrounding-tissue dose concepts, and radiation protection—not detailed isotope characteristic recall.
If an HDR source fails to retract, follow the posted emergency sequence: stop/secure, remove the patient per protocol, survey, and notify radiation safety/physics immediately.
Sealed sources require inventory control and periodic leak testing under regulatory programs; treat discrepancies as radiation-safety events.
Transport package category labels communicate external dose-rate levels; therapists handle packages only within institutional radiation-safety procedures.
Last updated: July 2026
Radiation Safety Rules, Emergency Procedures & Sealed Source Safety
ARRT exam scope note: Content specifications state that only basic concepts related to common uses of brachytherapy are covered, including dose to surrounding tissue and radiation protection issues. Specific procedures and isotope characteristics are not covered. Memorizing exact half-lives and emission energies is outside the intended exam emphasis; focus on protection, inventory control, and surrounding-tissue dose concepts.
Quick Reference: Brachytherapy employs sealed radioactive sources placed directly within or adjacent to tumor volumes. Safe management requires strict source inventory accounting, semi-annual leak testing, compliance with Department of Transportation (DOT) shipping categories, and emergency action plans for stuck HDR sources.
Brachytherapy Isotope Physics & Decay Characteristics
Brachytherapy is classified by dose rate under ICRU definitions:
Low Dose Rate (LDR): 0.4 to 2.0 Gy/hour 0.4 \text{ to } 2.0\text{ Gy/hour} 0.4 to 2.0 Gy/hour (e.g., permanent prostate seed implants).
Medium Dose Rate (MDR): 2.0 to 12.0 Gy/hour 2.0 \text{ to } 12.0\text{ Gy/hour} 2.0 to 12.0 Gy/hour .
High Dose Rate (HDR): > 12.0 Gy/hour > 12.0\text{ Gy/hour} > 12.0 Gy/hour ( 0.2 Gy/minute 0.2\text{ Gy/minute} 0.2 Gy/minute , typically delivering treatments in 5 − 15 minutes 5-15\text{ minutes} 5 − 15 minutes using a single high-activity Iridium-192 source of ∼ 10 Ci \sim 10\text{ Ci} ∼ 10 Ci ).
Commonly Used Sealed Sources
Focus for ARRT What to know
Surrounding-tissue dose Inverse-square falloff near sources protects adjacent organs relative to implanted/adjacent target dose
Radiation protection Time, distance, shielding, inventory, afterloader interlocks, and emergency retract procedures
Exam non-emphasis Exact isotope half-lives, emission energies, and procedure minutiae are outside ARRT’s stated scope
HDR Afterloader Safety & Stuck Source Emergency Protocols
HDR remote afterloaders drive a miniature 10 Ci 10\text{ Ci} 10 Ci Ir-192 source attached to a flexible drive cable through transfer tubes into patient applicators.
Daily Quality Assurance Interlock Checks
Before treating the first patient each day, safety interlocks must be verified:
Console Emergency Off Button: Must immediately retract the source.
Door Interlock Switch: Opening the vault treatment door during beam-on must instantly retract the source into the shielded safe.
Room Radiation Monitor & Alarm Light: Independent wall-mounted GM monitor must flash visible lights when the source is deployed.
Audio/Visual Intercom Systems: Dual cameras and two-way intercom must be functional.
Emergency Response Protocol for a Stuck HDR Source
If the high-activity Ir-192 source fails to retract automatically upon treatment completion, the clinical team must execute the following sequential emergency protocol: [1. Press Emergency Off] ===> [2. Manual Crank Attempt] ===> [3. Grab GM Meter & Forceps]
- |
- [6. Notify RSO & NRC] <=== [5. Evacuate Patient & Lock] <=== [4. Place Applicator in Lead Pig]
Step 1: Press Console Emergency Stop / Off Button: Triggers primary electrical and spring-loaded mechanical emergency retraction.
Step 2: Attempt Manual Retraction: Turn the manual hand-crank on the afterloader unit in the retract direction.
Step 3: Enter Vault with Survey Instrument: If source remains exposed, grab a calibrated Geiger-Müller survey meter and the emergency container kit (long-handled forceps, heavy lead storage pig), and enter the treatment room immediately.
Step 4: Secure Source / Applicator: Disconnect the transfer tube/applicator from the patient. Using long-handled forceps (maintaining distance), pick up the applicator containing the stuck source, place it into the emergency lead pig container, and close the lead lid.
Step 5: Evacuate Patient & Secure Room: Help the patient exit the treatment vault immediately. Lock the vault door to prevent unauthorized entry and post warning signs.
Step 6: Notify Safety Authorities: Immediately contact the Radiation Safety Officer (RSO) , medical physicist, and manufacturer engineer. The RSO must report the incident to the NRC Operations Center .
Sealed Source Inventory, Leak Testing & Regulations
Sealed radioactive sources must be strictly controlled under NRC 10 CFR Part 35 .
Semi-Annual Leak Testing Protocols
Requirement: All sealed sources containing byproduct material with a half-life greater than 30 days 30\text{ days} 30 days must be leak tested at least once every 6 months (semi-annually).
Removable Contamination Limit: A source is deemed leaking if wipe test analysis detects removable radioactive contamination equal to or exceeding 185 Bq 185\text{ Bq} 185 Bq ( 0.005 μ Ci 0.005\mu\text{Ci} 0.005 μ Ci or 11 , 100 dpm 11,100\text{ dpm} 11 , 100 dpm ) .
Action Required: If a source exceeds 185 Bq 185\text{ Bq} 185 Bq , it must be immediately withdrawn from use, placed in a sealed storage container, and reported in writing to the NRC within 5 days 5\text{ days} 5 days .
Source Inventory & Accountability
Facilities must maintain an up-to-date physical inventory log recorded at least quarterly, recording:
Source radionuclide, serial number, and original activity.
Location of source (safe vs. patient applicator).
Removal and return dates, signed by the authorized user.
Radiation survey reading of safe perimeter.
Department of Transportation (DOT) Package Shipping & Labeling
Transporting radioactive sources outside the facility is regulated by the Department of Transportation (DOT 49 CFR) .
Package Label Categories & Exposure Limits
Packages are classified into three warning categories based on surface radiation levels and the Transport Index (TI) :
DOT Label Category Surface Radiation Dose Rate Dose Rate at 1 Meter (Transport Index / TI)
White I (Low Hazard) ≤ 0.5 mR/hr \le 0.5\text{ mR/hr} ≤ 0.5 mR/hr ( 0.005 mSv/hr 0.005\text{ mSv/hr} 0.005 mSv/hr ) TI = 0 \text{TI} = 0 TI = 0 (Background radiation at 1 m 1\text{ m} 1 m )
Yellow II (Medium Hazard) > 0.5 mR/hr > 0.5\text{ mR/hr} > 0.5 mR/hr up to 50 mR/hr 50\text{ mR/hr} 50 mR/hr ( 0.5 mSv/hr 0.5\text{ mSv/hr} 0.5 mSv/hr ) TI ≤ 1.0 \text{TI} \le 1.0 TI ≤ 1.0 ( 1.0 mR/hr 1.0\text{ mR/hr} 1.0 mR/hr at 1 m 1\text{ m} 1 m )
Yellow III (High Hazard) > 50 mR/hr > 50\text{ mR/hr} > 50 mR/hr up to 200 mR/hr 200\text{ mR/hr} 200 mR/hr ( 2.0 mSv/hr 2.0\text{ mSv/hr} 2.0 mSv/hr ) TI > 1.0 \text{TI} > 1.0 TI > 1.0 up to 10.0 10.0 10.0 ( 10.0 mR/hr 10.0\text{ mR/hr} 10.0 mR/hr at 1 m 1\text{ m} 1 m )
Definition of Transport Index (TI)
The Transport Index (TI) is a dimensionless number printed on Yellow II and Yellow III shipping labels. It is defined specifically as the maximum radiation dose rate in millirem per hour (mrem/hr) measured at a distance of 1 meter from the external surface of the package. Example: A dose rate of 2.5 mrem/hr 2.5\text{ mrem/hr} 2.5 mrem/hr measured at 1 meter 1\text{ meter} 1 meter corresponds to a TI = 2.5 \text{TI} = 2.5 TI = 2.5 .